STEAP2 and prostate neoplasm: First, STEAP2 displays an ideal expression profile for targeting as compared with many other prostate tumor antigens due to limited distal normal tissue expression, as evaluated by IHC (Table 1), the Human Protein Atlas, and proteomic data sets.